Effect of eplerenone on maintenance of sinus rhythm after catheter ablation in patients with long-standing persistent atrial fibrillation

American Journal of Cardiology

Volumn 111, Issue 7, 2013, Pages 1012-1018

  Ito, Yoko ^a   Yamasaki, Hiro ^a   Naruse, Yoshihisa ^a   Yoshida, Kentaro ^a   Kaneshiro, Takashi ^a   Murakoshi, Nobuyuki ^a   Igarashi, Miyako ^a   Kuroki, Kenji ^a   Machino, Takeshi ^a   Xu, Dongzhu ^a   Kunugita, Fusanori ^a   Sekiguchi, Yukio ^a   Sato, Akira ^a   Tada, Hiroshi ^a   Aonuma, Kazutaka ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; EPLERENONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ARTICLE; CATHETER ABLATION; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; LONG STANDING PERSISTENT ATRIAL FIBRILLATION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SINUS RHYTHM; THERAPY EFFECT;

ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; CATHETER ABLATION; CHI-SQUARE DISTRIBUTION; COMBINED MODALITY THERAPY; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HUMANS; MALE; MIDDLE AGED; MINERALOCORTICOID RECEPTOR ANTAGONISTS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SPIRONOLACTONE; TREATMENT OUTCOME;

EID: 84875211885     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.12.020     Document Type: Article

References (29)

1. O.M. Wazni, N.F. Marrouche, D.O. Martin, A. Verma, M. Bhargava, W. Saliba, D. Bash, R. Schweikert, J. Brachmann, J. Gunther, K. Gutleben, E. Pisano, D. Potenza, R. Fanelli, A. Raviele, S. Themistoclakis, A. Rossillo, A. Bonso, and A. Natale Radiofrequency ablation vs. antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation, a randomized trial JAMA 293 2005 2634 2640
2. J.P. Piccini, R.D. Lopes, M.H. Kong, V. Hasselblad, K. Jackson, and S.M. Al-Khatib Pulmonary vein isolation for the maintenance of sinus rhythm in patients with atrial fibrillation: a meta-analysis of randomized, controlled trials Circ Arrhythm Electrophysiol 2 2009 626 633
3. R.R. Tilz, A. Rillig, A.M. Thum, A. Arya, P. Wohlmuth, A. Metzner, S. Mathew, Y. Yoshiga, E. Wissner, K.H. Kuck, and F. Ouyang Catheter ablation of long-standing persistent atrial fibrillation: 5-year outcomes of the Hamburg sequential ablation strategy J Am Coll Cardiol 60 2012 1921 1929
4. J.S. Healey, A. Baranchuk, E. Crystal, C.A. Morillo, M. Garfinkle, S. Yusuf, and S.J. Connolly Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis J Am Coll Cardiol 45 2005 1832 1839
5. I. Savelieva, N. Kakouros, A. Kourliouros, and A.J. Camm Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention Europace 13 2011 308 328
6. A.D. Struthers The clinical implications of aldosterone escape in congestive heart failure Eur J Heart Fail 6 2004 539 545
7. A.V. Chobanian, G.L. Bakris, H.R. Black, W.C. Cushman, L.A. Green, J.L. Izzo Jr., D.W. Jones, B.J. Materson, S. Oparil, J.T. Wright Jr., and E.J. Roccella Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Hypertension 42 2003 1206 1252
8. T. Teramoto, J. Sasaki, H. Ueshima, G. Egusa, M. Kinoshita, K. Shimamoto, H. Daida, S. Biro, K. Hirobe, T. Funahashi, K. Yokote, and M. Yokode Diagnostic criteria for dyslipidemia. Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese J Atheroscler Thromb 14 2007 155 158
9. I. Wakabayashi Cross-sectional relationship between alcohol consumption and prevalence of metabolic syndrome in Japanese men and women J Atheroscler Thromb 17 2010 695 704
10. Y. Naruse, H. Tada, Y. Sekiguchi, T. Machino, M. Ozawa, H. Yamasaki, M. Igarashi, K. Kuroki, Y. Itoh, N. Murakoshi, I. Yamaguchi, and K. Aonuma Concomitant chronic kidney disease increases the recurrence of atrial fibrillation after catheter ablation of atrial fibrillation: a mid-term follow-up Heart Rhythm 8 2011 335 341
11. R. Da̧browski, and H. Szwed Antiarrhythmic potential of aldosterone antagonists in atrial fibrillation Cardiol J 3 2012 223 229
12. E.M. Balk, A.C. Garlitski, A.A. Alsheikh-Ali, T. Terasawa, M. Chung, and S. Ip Predictors of atrial fibrillation recurrence after radiofrequency catheter ablation: a systematic review J Cardiovasc Electrophysiol 21 2010 1208 1216
13. A.A. Hussein, W.I. Saliba, D.O. Martin, M. Shadman, M. Kanj, M. Bhargava, T. Dresing, M. Chung, T. Callahan, B. Baranowski, P. Tchou, B.D. Lindsay, A. Natale, and O.M. Wazni B-type natriuretic peptide levels and recurrent arrhythmia after successful ablation of lone atrial fibrillation Circulation 123 2011 2077 2082
14. Mulder AA, Wijffels MC, Wever EF, Boersma LV. Early recurrence of atrial fibrillation as a predictor for 1-year efficacy after successful phased RF pulmonary vein isolation: Evaluation of complaints and multiple Holter recordings. Int J Cardiol. In press.
15. J.M. McCabe, L.M. Smith, Z.H. Tseng, N. Badhwar, B.K. Lee, R.J. Lee, M.M. Scheinman, J.E. Olgin, and G.M. Marcus Protracted CRP elevation after atrial fibrillation ablation Pacing Clin Electrophysiol 31 2008 1146 1151
16. T. Koyama, H. Tada, Y. Sekiguchi, T. Arimoto, H. Yamasaki, K. Kuroki, T. Machino, K. Tajiri, X.D. Zhu, M. Kanemoto-Igarashi, A. Sugiyasu, K. Kuga, Y. Nakata, and K. Aonuma Prevention of atrial fibrillation recurrence with corticosteroids after radiofrequency catheter ablation: a randomized controlled trial J Am Coll Cardiol 56 2010 1463 1472
17. S. Deftereos, G. Giannopoulos, C. Kossyvakis, M. Efremidis, V. Panagopoulou, A. Kaoukis, K. Raisakis, G. Bouras, C. Angelidis, A. Theodorakis, M. Driva, K. Doudoumis, V. Pyrgakis, and C. Stefanadis Colchicine for prevention of early atrial fibrillation recurrence after pulmonary vein isolation: a randomized controlled study J Am Coll Cardiol 60 2012 1790 1796
18. S. Kimura, M. Ito, M. Tomita, M. Hoyano, H. Obata, L. Ding, M. Chinushi, H. Hanawa, M. Kodama, and Y. Aizawa Role of mineralocorticoid receptor on atrial structural remodeling and inducibility of atrial fibrillation in hypertensive rats Hypertens Res 34 2011 584 591
19. B.A. Schoonderwoerd, I.C. Van Gelder, D.J. Van Veldhuisen, M.P. Van den Berg, and H.J. Crijns Electrical and structural remodeling: role in the genesis and maintenance of atrial fibrillation Prog Cardiovasc Dis 48 2005 153 168
20. J.C. Reil, M. Hohl, S. Selejan, P. Lipp, F. Drautz, A. Kazakow, B.M. Munz, P. Müller, P. Steendijk, G.H. Reil, M.A. Allessie, M. Böhm, and H.R. Neuberger Aldosterone promotes atrial fibrillation Eur Heart J 33 2012 2098 2108
21. Y. Sun, J. Zhang, L. Lu, S.S. Chen, M.T. Quinn, and K.T. Weber Aldosterone-induced inflammation in the rat heart: role of oxidative stress Am J Pathol 161 2002 1773 1781
22. J. Ausma, M. Wijffels, F. Thoné, L. Wouters, M. Allessie, and M. Borgers Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat Circulation 96 1997 3157 3163
23. T.A. Aksnes, A. Flaa, A. Strand, and S.E. Kjeldsen Prevention of new-onset atrial fibrillation and its predictors with angiotensin II-receptor blockers in the treatment of hypertension and heart failure J Hypertens 25 2007 15 23
24. J. Zhao, J. Li, W. Li, Y. Li, H. Shan, Y. Gong, and B. Yang Effects of spironolactone on atrial structural remodelling in a canine model of atrial fibrillation produced by prolonged atrial pacing Br J Pharmacol 159 2010 1584 1594
25. R.S. Williams, J.A. Delemos, V. Dimas, J. Reisch, J.A. Hill, and R.H. Naseem Effect of spironolactone on patients with atrial fibrillation and structural heart disease Clin Cardiol 34 2011 415 419
26. F. Zannad, J.J. McMurray, H. Krum, D.J. van Veldhuisen, K. Swedberg, H. Shi, J. Vincent, S.J. Pocock, B. Pitt EMPHASIS-HF Study Group Eplerenone in patients with systolic heart failure and mild symptoms N Engl J Med 364 2011 11 21
27. J.G. Cleland, A.P. Coletta, T. Castiello, and A.L. Clark Clinical trials update from the European Society of Cardiology Heart Failure meeting 2011: TEHAF, WHICH, CARVIVA, and atrial fibrillation in GISSI-HF and EMPHASIS-HF Eur J Heart Fail 13 2011 1147 1151
28. C.T. Tsai, F.T. Chiang, C.D. Tseng, J.J. Hwang, K.T. Kuo, C.K. Wu, C.C. Yu, Y.C. Wang, L.P. Lai, and J.L. Lin Increased expression of mineralocorticoid receptor in human atrial fibrillation and a cellular model of atrial fibrillation J Am Coll Cardiol 55 2010 758 770
29. G. Hindricks, C. Piorkowski, H. Tanner, R. Kobza, J.H. Gerds-Li, C. Carbucicchio, and H. Kottkamp Perception of atrial fibrillation before and after radiofrequency catheter ablation: relevance of asymptomatic arrhythmia recurrence Circulation 112 2005 307 313